Exploring Epigenetic Modifications as Potential Biomarkers and Therapeutic Targets in Glaucoma
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25052822 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Emanuele Tonti und 7 weiteren Autor:innen. Beteiligte Einrichtung: Eye Clinic, Policlinico Umberto I University Hospital, 00142 Rome, Italy. Hauptthemen laut MEDLINE: Glaucoma. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Glaucoma, a complex and multifactorial neurodegenerative disorder, is a leading cause of irreversible blindness worldwide. Despite significant advancements in our understanding of its pathogenesis and management, early diagnosis and effective treatment of glaucoma remain major clinical challenges. Epigenetic modifications, encompassing deoxyribonucleic acid (DNA) methylation, histone modifications, and non-coding RNAs, have emerged as critical regulators of gene expression and cellular processes. The aim of this comprehensive review focuses on the emerging field of epigenetics and its role in understanding the complex genetic and molecular mechanisms underlying glaucoma. The review will provide an overview of the pathophysiology of glaucoma, emphasizing the intricacies of intraocular pressure regulation, retinal ganglion cell dysfunction, and optic nerve damage. It explores how epigenetic modifications, such as DNA methylation and histone modifications, can influence gene expression, and how these mechanisms are implicated in glaucomatous neurodegeneration and contribute to glaucoma pathogenesis. The manuscript discusses evidence from both animal models and human studies, providing insights into the epigenetic alterations associated with glaucoma onset and progression. Additionally, it discusses the potential of using epigenetic modifications as diagnostic biomarkers and therapeutic targets for more personalized and targeted glaucoma treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Eye Clinic, Policlinico Umberto I University Hospital, 00142 Rome, Italy.
- Department of Medicine and Health Sciences "Vincenzo Tiberio", University of Molise, Via Francesco De Sanctis 1, 86100 Campobasso, Italy.
- Department of Ophthalmology, University Hospital of Udine, 33100 Udine, Italy.
- Faculty of Medicine and Surgery, University of Enna "Kore", Piazza dell'Università, 94100 Enna, Italy.
- Eye Clinic, Catania University, San Marco Hospital, Viale Carlo Azeglio Ciampi, 95121 Catania, Italy.
- Department of Optometry, University of Benin, Benin City 300238, Nigeria.
ORCID-Profile: Roberto Dell'Omo, Mariaelena Filippelli, Leopoldo Spadea, Caterina Gagliano, Mutali Musa, Marco Zeppieri
Zitieren
APA
Tonti, E., Dell'Omo, R., Filippelli, M., Spadea, L., Salati, C., Gagliano, C., Musa, M., & Zeppieri, M. (2024). Exploring Epigenetic Modifications as Potential Biomarkers and Therapeutic Targets in Glaucoma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25052822
Vancouver
Tonti E, Dell'Omo R, Filippelli M, Spadea L, Salati C, Gagliano C, et al. Exploring Epigenetic Modifications as Potential Biomarkers and Therapeutic Targets in Glaucoma. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25052822
BibTeX
@article{Tonti2024,
author = {Tonti, Emanuele and Dell'Omo, Roberto and Filippelli, Mariaelena and Spadea, Leopoldo and Salati, Carlo and Gagliano, Caterina and Musa, Mutali and Zeppieri, Marco},
title = {Exploring Epigenetic Modifications as Potential Biomarkers and Therapeutic Targets in Glaucoma},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25052822}
}
EUVIMED